DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20160387

Efficacy of LNG IUS

Uma Pandey

Abstract


Background: Objective of the study was to find out improvement in menstrual symptoms with Levonorgestrel Intrauterine System (LNG IUS) among women presenting with heavy menstrual bleeding.

Methods: LNG IUS was inserted in women presenting to Gynaecology outpatients department with complains of heavy menstrual bleeding (HMB), pain or for contraception. The age range was 37-46 years. Endometrial biopsy was done in all patients. Only those women with LNG IUS use were included in the study who continued to visit us for at least 6 months.

Results: There were 35 women who were included in this observational study. 94.28% (33/35) women had LNG IUS inserted in theatre whilst 5.7% (2/35) had in the outpatients department. There was improvement in menstrual symptoms in 80% of the patients. There was no relief in the endometriosis group. Total abdominal hysterectomy was performed in 7 women who had endometriosis (20%).

Conclusions: In my observational study 80% of women are satisfied with the device and had relief in their symptoms. In view of HMB’s high prevalence, an optimal treatment for this kind of menstrual symptoms is very important especially in developing world set up where resources aren’t easily available.

 


Keywords


Heavy menstrual bleeding, Levonorgestel Intrauterine System, Endometrial biopsy, Hysterectomy

Full Text:

PDF

References


Palep-Singh M, Prentice A. Epidemiology of abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2007;21(6):887-90.

Shapely M, Jordan K, Croft PR. An epidemiological survey of symptoms of menstrual loss in the community. Br J Gen Pract. 2004;54(502):359-63.

Lethaby AE, Cooke I, Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2005;4:CD002126.

Cooper K, Lee A, Chien P, Raja E, Timmaraju V, Bhattacharya S. Outcomes following hysterectomy or endometrial ablation for heavy menstrual bleeding: Retrospective analysis of hospital episode statistics in Scotland. BJOG. 2011;118(10):1171-9.

Abbott JA, Garry R. The surgical management of menorrhagia. Hum Reprod Update 2002, 8 (1):68-78.

Shaw RW. Assessment of medical treatments for menorrhagia. Br J Obstet Gynaecol. 1994;101(11):15-8.

Nagele F, Rubinger T, Magos A. Why do women choose endometrial ablation rather than hysterectomy? Fertil Steril. 1998;69(6):1063-6.

Lahteenmaki P, Haukkamaa M, Puolakka J. Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. BMJ. 1998;316(7138):1122-6.

Milsom I, Andersson K, Andersch B, Rybo G. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol. 1991;164(3):879-83.

Crosignani PG, Vercellini P, Mosconi P, Oldani S, Cortesi I, De Giorgi O. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol. 1997;90(2):257-63.

Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkila A, Walker JJ. Cameron IT: Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol. 1998;105(6):592-8.

Ewies AA. Levonorgestrel-releasing intrauterine system-the discontinuing story. Gynecol Endocrinol. 2009;25(10):668-73.